Industry Trends
Nature Biotechnology 15, 479 - 480 (1997)
doi:10.1038/nbt0597-479
The carbohydrate-based drug industry
Aris Persidis1
Abstract
Whether used as a target or a tool carbohydrates face manufacturing challenges before they can realize their true value.
- 1Aris Persidis is vice president for business development, Argonex Inc., 2044 India Road, Charlottesville, VA 22901 (apersidis@argonex. com).


